Summarises incidence and mechanisms of NAI resistance in seasonal influenza viruses and availability of NAI susceptibility testing in UK.
Ref: PHE publications gateway number: 2016468 PDF, 147KB, 12 pages
This file may not be suitable for users of assistive technology. Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email email@example.com. Please tell us what format you need. It will help us if you say what assistive technology you use.
This information is for laboratory scientists, clinicians and public health practitioners with responsibility for influenza virus diagnostic testing, the management of patients receiving neuraminidase inhibitor (NAI) prophylaxis or treatment or investigation of influenza virus outbreaks.